ArticleTherapeutic advances in medical oncology2020

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors.

Filippo G Dall'Olio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.